Federal contract award
W912DY23C0018
ESPC - CONTINUED CONTRACT FOR DACA87-97-D-0069-0011 PAYMENTS 127-132, POP APRIL - SEPTEMBER 2023
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W2V6 USA ENG SPT CTR HUNTSVIL |
| NAICS | 541330 — Engineering Services |
| PSC | R425 — Engineering and Technical Services |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.7M |
| Current contract value | $1.7M |
| Potential contract value / ceiling | $8.1M |
| Start date | May 16, 2011 |
| Current end date | Mar 31, 2026 |
| Potential end date | Sep 30, 2030 |
| Latest award activity | Mar 27, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 7 of 7 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 27, 2026 | P00014 | $126.6K | THE PURPOSE OF THIS MODIFICATION IS TO ESTABLISH CLIN 0017 AND OBLIGATE FY26 FUNDS FOR MONTHLY P/I AND PERFORMANCE PERIOD EXPENSE PAYMENTS 160 - 162 IN THE AMOUNT OF $126,649.92. ALL OTHER TERMS AND CONDITIONS REMAIN THE SAME. |
| Dec 11, 2025 | P00013 | $126.6K | THE PURPOSE OF THIS MODIFICATION IS TO ESTABLISH CLIN 0016 AND OBLIGATE FY26 FUNDS FOR MONTHLY P AND I AND PERFORMANCE PERIOD EXPENSE PAYMENTS 157-159 IN THE AMOUNT OF $126,649.92. IAW FINANCIAL SCHEDULE, 16 MAY 2011 INCORPORATED ON 29 SEPT 2023. |
| Jun 6, 2025 | P00012 | $163.0K | THE PURPOSE OF THIS MODIFICATION IS TO ESTABLISH CLIN 0015 AND OBLIGATE FY25 FUNDS FOR MONTHLY P&I AND PERFORMANCE PERIOD EXPENSE PAYMENTS 153-156 IN THE AMOUNT OF $162,990.95 |
| May 16, 2025 | P00011 | $40.7K | THE PURPOSE OF THIS ACTION IS TO ESTABLISH CLIN 0014 AND OBLIGATE FY25 FUNDS FOR PAYMENT 152 IN THE AMOUNT OF $40,747.75 |
| Apr 4, 2025 | P00010 | $40.7K | THE PURPOSE OF THIS ACTION IS TO ESTABLISH CLIN 0013 AND OBLIGATE FY25 FUNDS FOR PAYMENT 151 IN THE AMOUNT OF $40,747.75 |
| Jan 24, 2025 | P00009 | $81.5K | THE PURPOSE OF THIS ACTION IS TO ESTABLISH CLIN 0012 AND OBLIGATE FY25 FUNDS FOR PAYMENTS 149-150 IN THE AMOUNT OF $40,747.75 EACH FOR A TOTAL OBLIGATION AMOUNT OF $81,495.50 |
| Oct 31, 2024 | P00008 | $122.2K | THE PURPOSE OF THIS ACTION IS TO ESTABLISH CLIN 0011 AND OBLIGATE FY25 FUNDS FOR PAYMENTS 146-148 IN THE AMOUNT OF $40,747.75 EACH FOR A TOTAL OBLIGATION AMOUNT OF $122,243.25, IAW FINANCIAL SCHEDULE DTD. 16 MAY 2011 INCORPORATED 29 SEP 2023. |
Estimated positioning window
Sep 30, 2029 – Mar 30, 2030
40/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 40/100. Available recorded signals: 35 points.
- Contract end 2030-09-30 (1429 days from calculation)
- +5 points
- 130 historical awards in this buyer and category group
- +15 points
- 7 recorded award transactions
- +10 points
- Latest award action: 2026-03-27
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.